Alterity Therapeutics Limited Stock Probability of Future Pink Sheet Price Finishing Over 0
| PRNAF Stock | USD 0 0.00 0.00% |
Alterity |
Alterity Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Alterity Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Alterity Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Alterity Therapeutics generated a negative expected return over the last 90 days | |
| Alterity Therapeutics has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (12.85 M) with profit before overhead, payroll, taxes, and interest of 4.76 M. | |
| Alterity Therapeutics Limited has accumulated about 34.81 M in cash with (12.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 15.0% of the company outstanding shares are owned by corporate insiders |
Alterity Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Alterity Pink Sheet often depends not only on the future outlook of the current and potential Alterity Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Alterity Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 2.4 B |
Alterity Therapeutics Technical Analysis
Alterity Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. Alterity Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Alterity Therapeutics Limited. In general, you should focus on analyzing Alterity Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Alterity Therapeutics Predictive Forecast Models
Alterity Therapeutics' time-series forecasting models is one of many Alterity Therapeutics' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Alterity Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Alterity Therapeutics
Checking the ongoing alerts about Alterity Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Alterity Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Alterity Therapeutics generated a negative expected return over the last 90 days | |
| Alterity Therapeutics has some characteristics of a very speculative penny stock | |
| Net Loss for the year was (12.85 M) with profit before overhead, payroll, taxes, and interest of 4.76 M. | |
| Alterity Therapeutics Limited has accumulated about 34.81 M in cash with (12.34 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 15.0% of the company outstanding shares are owned by corporate insiders |
Other Information on Investing in Alterity Pink Sheet
Alterity Therapeutics financial ratios help investors to determine whether Alterity Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Alterity with respect to the benefits of owning Alterity Therapeutics security.